MicroPort NeuroScientific (2172) Stock Overview
Provides neuro-interventional medical devices. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 2172 from our risk checks.
2172 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
MicroPort NeuroScientific Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$14.75 |
| 52 Week High | HK$19.06 |
| 52 Week Low | HK$6.92 |
| Beta | -0.14 |
| 1 Month Change | 10.40% |
| 3 Month Change | 47.21% |
| 1 Year Change | 110.71% |
| 3 Year Change | -39.55% |
| 5 Year Change | n/a |
| Change since IPO | -40.04% |
Recent News & Updates
Optimistic Investors Push MicroPort NeuroScientific Corporation (HKG:2172) Shares Up 25% But Growth Is Lacking
Aug 10
MicroPort NeuroScientific (HKG:2172) Could Be Struggling To Allocate Capital
Jul 29MicroPort NeuroScientific (HKG:2172) Will Pay A Dividend Of CN¥0.11
Jun 26Recent updates
Optimistic Investors Push MicroPort NeuroScientific Corporation (HKG:2172) Shares Up 25% But Growth Is Lacking
Aug 10MicroPort NeuroScientific (HKG:2172) Could Be Struggling To Allocate Capital
Jul 29MicroPort NeuroScientific (HKG:2172) Will Pay A Dividend Of CN¥0.11
Jun 26MicroPort NeuroScientific Corporation (HKG:2172) Looks Just Right With A 30% Price Jump
Jun 22MicroPort NeuroScientific's (HKG:2172) Dividend Will Be CN¥0.11
Jun 02MicroPort NeuroScientific Corporation's (HKG:2172) Share Price Is Still Matching Investor Opinion Despite 28% Slump
Apr 17MicroPort NeuroScientific (HKG:2172) Has Announced A Dividend Of CN¥0.11
Mar 31Some MicroPort NeuroTech Limited (HKG:2172) Shareholders Look For Exit As Shares Take 28% Pounding
Jun 29MicroPort NeuroTech (HKG:2172) Will Want To Turn Around Its Return Trends
Apr 26Is MicroPort NeuroTech Limited (HKG:2172) Trading At A 36% Discount?
Mar 05Returns On Capital At MicroPort NeuroTech (HKG:2172) Have Hit The Brakes
Jan 18Calculating The Fair Value Of MicroPort NeuroTech Limited (HKG:2172)
Nov 04Shareholders Will Be Pleased With The Quality of MicroPort NeuroTech's (HKG:2172) Earnings
Sep 29Investors Could Be Concerned With MicroPort NeuroTech's (HKG:2172) Returns On Capital
Aug 04Shareholder Returns
| 2172 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -6.2% | -1.6% | 0.5% |
| 1Y | 110.7% | 98.2% | 43.4% |
Return vs Industry: 2172 exceeded the Hong Kong Medical Equipment industry which returned 98.2% over the past year.
Return vs Market: 2172 exceeded the Hong Kong Market which returned 43.4% over the past year.
Price Volatility
| 2172 volatility | |
|---|---|
| 2172 Average Weekly Movement | 10.3% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in HK Market | 15.7% |
| 10% least volatile stocks in HK Market | 3.5% |
Stable Share Price: 2172 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2172's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 527 | Zhiyong Xie | www.microportneurosci.com |
MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk, a 3D electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for intracranial aneurysm, as well as liquid embolic agent for cerebral arteriovenous malformations. It also offers APOLLO intracranial stent system for intracranial atherosclerosis; Bridge rapamycin target eluting and Bridge MAX rapamycin target eluting vertebral artery stent system for vertebral artery stenosis; Diveer intracranial balloon dilatation catheter, intracranial drug-coated balloon catheter system, intracranial self-expanding rapamycin target eluting stent, and intracranial balloon-expandable rapamycin target eluting stent for intracranial stenosis; and Carotid stent system, Safecer embolic protection device, and PathFinder carotid balloon dilation catheter for carotid artery stenosis.
MicroPort NeuroScientific Corporation Fundamentals Summary
| 2172 fundamental statistics | |
|---|---|
| Market cap | HK$8.49b |
| Earnings (TTM) | HK$277.24m |
| Revenue (TTM) | HK$830.93m |
Is 2172 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2172 income statement (TTM) | |
|---|---|
| Revenue | CN¥761.76m |
| Cost of Revenue | CN¥205.84m |
| Gross Profit | CN¥555.93m |
| Other Expenses | CN¥301.76m |
| Earnings | CN¥254.17m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Aug 27, 2025
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 72.98% |
| Net Profit Margin | 33.37% |
| Debt/Equity Ratio | 0% |
How did 2172 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/24 06:18 |
| End of Day Share Price | 2025/08/22 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MicroPort NeuroScientific Corporation is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuan Gao | China International Capital Corporation Limited |
| Hanqing Zhu | J.P. Morgan |
| Yin Ye | Ping An Securities Co. Ltd. |